Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) - Global Forecast to 2028
... expected to reach USD 479.0 billion by 2028 from USD 247.3 billion in 2023, at a CAGR of 14.1%during the forecast period. The key factors driving the growth of the antibody therapeutics market include the ... Read More
-
United States In Vitro Diagnostics Market Assessment, By Product Type [Instruments, Reagents & Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Haemostasias, Urinalysis, Others] By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F
... By Application [Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F United States in vitro ... Read More
-
Japan In Vitro Diagnostics Market Assessment By Product Type [Instruments, Reagents and Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Haemostasias, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... Application [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F Japan In Vitro Diagnostics Market size ... Read More
-
Autoimmune Diseases Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2028
... Antibody Test, Autoantibody Test, Complete Blood Count, Comprehensive Metabolic Panel, C-Reaction Protein, Erythrocyte Sedimentation Rate, And Urinalysis), By End-User (Hospitals & Clinics, Diagnostics Centers, And Others) and geography is expected to grow at a steady ... Read More
-
Virtual Clinical Trials Market Size, Share, and Analysis, By Study Type (Interventional, Observational, Expanded Access), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (CNS, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Others) and Regional Forecasts, 2022-2032
... Genitourinary, Ophthalmology, Others) and Regional Forecasts, 2022-2032 Virtual Clinical Trials Market Size, Share, and Analysis, By Study Type (Interventional, Observational, Expanded Access), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (CNS, ... Read More
-
Autoimmune Drugs Markets in China
... maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, ... Read More
-
Autoimmune Drugs Industry Forecasts - China Focus
... manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China ... Read More
-
Autoimmune Drugs Companies in China
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More
-
Global Myasthenia Gravis Treatment Market: Forecast and Trends
... type, treatment by drug and region. Report Includes: 54 data tables and 47 additional tables An overview and analysis of the global market for myasthenia gravis (MG) treatments Analyses of market trends, with historical market ... Read More
-
Global Autoimmune Disease Diagnostics Market 2024-2028
... autoimmune disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Immunoassay Market based on by Product (Reagents and Kits, Analyzers/Instruments, Software and Services), Technology [Radioimmunoassay (RIA), Enzyme-linked Immunosorbent Assay (ELISA), Enzyme-linked Fluorescent Assay (ELFA), Chemiluminescence Immunoassay (CLIA), Rapid Test, Others], Indication (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Diseases, Autoimmune Diseases, Others), End User (Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical and Biotechnology Companies, Academic) and Regional Outlook– Global Forecast up to 2030
... Cardiology, Endocrinology, Infectious Diseases, Autoimmune Diseases, Others), End User (Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical and Biotechnology Companies, Academic) and Regional Outlook– Global Forecast up to 2030 A significant amount of secondary sources, directories, and ... Read More
-
Nanobody Market Research Report Forecast till 2030
... interest in nanobody innovative work are driving market development. Nanobodies are little counter acting agent parts that enjoy a few upper hands over conventional antibodies, like more prominent strength, better tissue infiltration, and decreased immunogenicity. ... Read More
-
Global Eosinophilic Esophagitis (EoE) Treatment Market - 2023-2030
... during the forecast period 2023-2030. Eosinophilic esophagitis (EoE) is a chronic allergic or immune disorder of the digestive system in which large numbers of white blood cells called eosinophils are present in the esophagus. It ... Read More
-
HPAPI and Cytotoxic Drug Manufacturing Market (4th Edition), 2022-2035
... and cytotoxic drugs have emerged as one of the key areas of interest for researchers and drug developers worldwide. As is well known, HPAPIs are pharmacologically active compounds which are capable of eliciting a biological ... Read More
-
Biopharmaceutical Market Size, Share, and Analysis, By Product Type (Purified Proteins, Recombinant Growth Factors, Recombinant Proteins, Recombinant Hormone, Synthetic Immunomodulatory, Monoclonal Antibodies, Vaccines, Other), By Service (Custom Testing / Customer Proprietary Testing, Laboratory Testing, Compendial, and Multi Compendial Laboratory Testing), By Raw Material Type (Active Pharmaceutical Ingredients (API), Formulation Excipients, Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support), By Application (Autoimmune Disorders, Metabolic Disorders, Oncology, Inflammatory and Infectious Diseases, Hormonal Disorders, Neurological Diseases, Cardiovascular Diseases, and Other) and Regional Forecasts, 2022-2032
... and Multi Compendial Laboratory Testing), By Raw Material Type (Active Pharmaceutical Ingredients (API), Formulation Excipients, Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support), By Application (Autoimmune Disorders, Metabolic Disorders, Oncology, Inflammatory and Infectious ... Read More
-
Global Autoimmune Diagnostics Market - 2023-2030
... period 2023-2030. Autoimmune diseases have no cure; addressing and managing the symptoms is very important. Autoimmune disease diagnosis helps detect the illness's root cause so that the proper treatment is given to the patient to ... Read More
-
Global Chronic Immune Thrombocytopenia Market - 2023-2030
... the forecast period 2023-2030. Chronic Immune Thrombocytopenia (ITP) is an autoimmune bleeding disorder that occurs due to decreased platelet secretion, preventing blood clotting. An average platelet count ranges from approximately 150,000 to 400,000 per blood ... Read More
-
Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
... and opportunities, R&D strategies, pipeline assessment, and market outlook. Myasthenia Gravis (MG) is an autoimmune and neuromuscular disease that is characterized by muscle weakness and fatigue. In the majority of patients, the disease is initially ... Read More
-
Global Rheumatoid Arthritis Drugs Market 2024-2028
... rheumatoid arthritis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
South & Central America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The South & Central America clinical trials market is expected to grow from US$ 1,794.69 million in 2022 to US$ 2,523.98 million by 2028. It ... Read More
-
Middle East & Africa Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Middle East & Africa clinical trials market is expected to grow from US$ 1,524.94 million in 2022 to US$ 1,923.39 million by 2028. It ... Read More
-
North America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The North America clinical trials market is expected to grow from US$ 27,322.28 million in 2022 to US$ 36,818.15 million by 2028. It is estimated to grow ... Read More
-
Europe Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Europe clinical trials market is expected to grow from US$ 15,739.35 million in 2022 to US$ 21,643.87 million by 2028. It is estimated to grow at a ... Read More
-
Asia Pacific Clinical Trials Market Forecast to 2028 – Regional Analysis – by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Asia Pacific clinical trials market is expected to grow from US$ 8,670.68 million in 2022 to US$ 13,114.04 million by 2028. It is estimated to grow ... Read More
-
Autoimmune Disease Diagnosis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 5.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028. The increasing incidences of autoimmune diseases, rising sales of insurance policies, and the growing use of EMRs represent ... Read More
Research Assistance
